Antimicrobial resistance (AMR) is one of the top global public health and development threats. According to a 2022 article published in the Lancet, it is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019 and contributed to 4.95 million deaths.
BioInfect will focus on the issues surrounding the increasing threat of AMR and how it can be addressed, including working towards an integrated, unifying approach that aims to achieve optimal and sustainable health outcomes; antimicrobial stewardship; increased investment and innovation in new treatments at all stages of the drug development pipeline and ensuring ROI in the development of new antimicrobials; and the use of strategic information to inform the AMR response.
Events >
Collaborative Masterclasses: Thriving Cultures Find out more
Embracing learning and growth in the era of psychological safety
Collaborative Masterclasses: Climate Change and the Public Sector Find out more
Bionow BioAI Summit Find out more
Bridging Life Sciences and Artificial Intelligence
HIVE Conference Find out more
A space for cross-pollination in health and care.
The Medilink Healthcare Business Awards 2025 Find out more
The Medilink Healthcare Business Awards is a calendar highlight and has seen some of the industry’s highly commendable innovations and successes receive the recognition they deserve over the years.